SCHEMBL7985859

SCHEMBL7985859

CCCc1nc2ncn(Cc3cccnc3)c2c(=O)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 1/20 0.49
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
ALDH1A1 P00352 2/20 0.45
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
KDM4C Q9H3R0 1/20 0.44
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.39
HCAR2 Q8TDS4 4/20 0.38
UBE2N P61088 1/20 0.38
ATM Q13315 1/20 0.38
BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989405 0.88 SMN1; SMN2 (0.57) CNOT7HPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7974253 0.86 HPGD (0.46) CNOT7HPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7985680 0.83 SMN1; SMN2 (0.53) CNOT7HPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL7985863 0.83 CNOT7 (0.57) CNOT7HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL7988657 0.83 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1KMT2ALMNA
SCHEMBL7989373 0.82 HPGD (0.46) HPGDSMN1; SMN2ALDH1A1KMT2ALMNA
SCHEMBL7991723 0.82 SMN1; SMN2 (0.49) HPGDSMN1; SMN2ALDH1A1KMT2AL3MBTL1
SCHEMBL7988482 0.82 PDE1A (0.46) HPGDSMN1; SMN2ALDH1A1KMT2AKDM4E
SCHEMBL7988953 0.81 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1KMT2AKDM4E
SCHEMBL7987608 0.81 SMN1; SMN2 (0.55) CNOT7HPGDSMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed